Mark Dybul Enochian Biosciences Inc (ENOB) insider trading activity

ENOB Quotes by TradingView

Mark Dybul is Chief Executive Officer of Enochian Biosciences Inc. Currently has a direct ownership of 66,196 shares of ENOB, which is worth approximately $304,501. The most recent transaction as insider was on Dec 14, 2020, when has been sold 180 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.2K
0% 3M change
0% 12M change
Total Value Held $304,501

Mark Dybul Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2020
BUY
Other acquisition or disposition
-
180 Added 0.27%
66,196 Common Stock
MD

Mark Dybul

Chief Executive Officer
Chestertown, MD

Track Institutional and Insider Activities on ENOB

Follow Enochian Biosciences Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENOB shares.

Notify only if
Any

Insider Trading

Get notified when an Enochian Biosciences Inc insider buys or sells ENOB shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Enochian Biosciences Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ENOB